![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/48 | |
A61P 25/02 |
(11) | Number of the document | 2280719 |
(13) | Kind of document | T |
(96) | European patent application number | 09734803.1 |
Date of filing the European patent application | 2009-04-27 | |
(97) | Date of publication of the European application | 2011-02-09 |
(45) | Date of publication and mention of the grant of the patent | 2016-09-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2009/005750 |
Date | 2009-04-27 |
(87) | Number | WO 2009/130600 |
Date | 2009-10-29 |
(30) | Number | Date | Country code |
0802321 | 2008-04-25 | FR |
(72) |
FAVRE, Christine, FR
AUGUET, Michel, FR
CHABRIER DE LASSAUNIERE, Pierre-Etienne, FR
|
(73) |
IPSEN PHARMA S.A.S.,
65, Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
(54) | THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY |
THERAPEUTIC USE OF BOTULINUM NEUROTOXIN TYPE A IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY |